 The research design is a randomized controlled trial RCT. This study is a two-arm, pre-post pilot study. Participants will be randomized into either an intervention arm or a wait-list control arm. Individuals randomized to the intervention arm will receive the six-week cognitive-existential intervention, and individuals randomized to the control arm will receive standard care at The Ottawa Hospital and be wait-listed for the intervention. Participants assigned to the control group will be informed at the beginning of the study that they will have the option to participate in the intervention after completing the control arm component 6 weeks later. Participants will be asked to complete a series of questionnaire packages. There will be 3 measurement occasions for participants randomized to the intervention group: one week prior to the intervention during the pre-therapy meeting, one week after the end of the intervention, and 3 months following the end of the intervention. There will be 4 measurement occasions for participants randomized to the control group: 6 weeks prior to the intervention during the pre-therapy meeting, immediately before the intervention begins, one week after the end of the intervention, and 3 months following the end of the intervention. Twenty n20 male and female cancer survivors from the greater Ottawa region will be recruited for the study. The aim is to recruit 10 males and 10 females from mixed cancer groups. Participants will be recruited from The Ottawa Hospital Cancer Centre TOHCC. Participants will be recruited from TOHCC through personalized letters, by TOHCC circle of care staff members, through posting of study posters throughout TOHCC, by display of study posters at various cancer organizations e.g., the Maplesoft Centre, and through use of OHRIs OBIEE tool. Individuals who are reached by personalized letter, by study posters, or through email will have the option to contact the research assistant via telephone for more information on the study. Participants who complete the patient information contact form will be asked to either return the form to their healthcare provider, or to place the form in the return box located in TOHCC waiting room. For individuals who complete the patient information contact form, the research assistant will collect the form and contact interested participants. Additionally, the investigators will use the OHRIs OBIEE tool to search for patients who have had a cancer diagnoses and have completed the TOH Consent to be Contacted for Research Purposes. The investigators will use the date range from January 2010-August 2014. The investigators will identify a pool of potential candidates for participation by requesting MOSAIC data from The Ottawa Hospital Cancer Centre. Once the investigators have this list of patients, they will screen the patient charts for eligibility to compile a list of potential participants who appear to be good candidates for the study. Patients who consented to be contacted for research may be contacted directly by a member of the research team or by their treating oncologist to inform about the study. Any patients for whom the investigators cannot find a signed consent to be contacted for research, a member of their circle of care e.g., oncologist or nurse will make the first contact and patients who are interested in learning more about the study and will then be contacted by the research coordinator. Participants will be screened for eligibility via telephone, and pre-therapy appointments will be set up should eligibility criteria be met. During the pre-therapy appointment, therapists will assess if participants are suitable for therapy, administer consent forms and the Mini-Mental State Examination, discuss general expectations, and prepare participants for the intervention. Once consent forms have been signed, participants will be assigned a participant number. All consent forms will be stored in a secured, locked room at the Ottawa Hospital, and will only be accessed by the research team. GPower 3.1.5 was used to calculate the necessary sample size for a repeated measures ANOVA, between factors, with two groups intervention group and standard care control group, and two measurement time points pre- and post-intervention, using the effect size that was found in Lebel and colleagues pilot study of 0.72 φ.80, p .05. To obtain this effect size, a sample of 14 participants is required. While 14 participants is the minimum number to detect a difference between groups based on these parameters, approximately 20 participants will be recruited, in order to account for attrition. 